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E coli 0157:H7 was first recognized as a human 
pathogen in 1982, when it was associated with two 
separate outbreaks of haemorrhagic colitis in the USA 1. 
Both outbreaks were linked to consumption of 
hamburgers. Since then, E coli 0157:H7 has emerged as 
a leading food-borne pathogen, particularly in North 
America 2 where its household name (,hamburger 
disease') underlines the important association of ground 
beef with the condition. 
Of particular public health concern are the serious 
c<?mplicarions of infection, namely haemorrhagic colitis 
and the haemolytic uraemic syndrome (HUS); the high 
frequency of secondary person-to-person transmission; 
the very low (possibly less than 100 organisms) infecting 
dose 3.4 and the established reservoir of the pathogen in 
cattle, In one review, I % of healthy cattle were 
intestinally colonised with E coli 0157 :H7 5. 
Ground beef is the most common vehicle for E coli 
0157 :H7 transmission in investigated outbreaks in the 
USA 6. Infection through contaminated beef can occur if 
it is insufficiently cooked (internal temperature less than 
68 0 C, or visibly uncooked with oozing blood inside), or 
if such meat contaminates ready-to-eat food. Beef may 
be contaminated during slaughter, and the process of 
grinding beef may transfer pathogens from the surface to 
the deep layers of meat. Since multiple carcases may be 
involved in one ground beef production, a small 
proportion of infected .animals in the 'pool' can cause 
widespread contamination. 
Other less common vehicles of infection described 
include vegetables, unpasteurized cow's milk, 
unpasteurized apple cider, yoghurt, mayonnaise and 
unchlorinated drinking water. Swimming in 
contaminated lake water and contact with raw cow 
manure have also been implicated 7, 
Person-to-person transmission has been an important 
mode of spread in day care centres 4,8, It was 
responsible for an outbreak in ' a nursing home in 
Canada 9, and was the mode of transmission to staff in an 
outbreak in institutions for the mentally subnormal 10 . A 
nurse caring for a child with HUS was infected by direct 
contact with the patient 11. 
Risk factors for infection include extremes of age 5, 
antimicrobial therapy administered early 8,'.1 and previous 
gastrectomy 8, Occupational exposure to cattle, to 
minced beef and to microbiological specimens and 
cultures in laboratories are also known hazards 12.13,14.15 . 
Clinical features 
E coli 0157:H7 infection causes a wide spectrum of 
disease ranging from asymptomatic carriage to severe 
disease leading to death. Typical disease includes a non­
bloody diarrhoea, haemorrhagic colitis, HUS and 
thrombotic thrombocytopaenic purpura 16 . While the 
incubation period is commonly 3-4 days, it can range 
from one to eight days 17,18,19. 
Infections caused by E coli 0157:H7 have been 
reported in many countries, and in many of them 
incidence appears to be increasing 20. The recent large 
outbreak of EHEC in Sakai City, Japan generated wide 
press interest: between 12 July and 16 August 1996, 
6561 persons were affected, mostly schoolchildren 
(96%). Ninety-two developed HUS and one died . 
Meanwhile, by 13 August , more than 9,200 individuals 
with EHEC were reported throughout the country , with 
nine associated deaths 21. 
Microbiology 
E coli 0157:H7 belongs to the enterohaemorrhagic 
(EHEC) subgroup. It produces two distinct lysogenic, 
bacteriophage-encoded toxins that inhibit protein­
synthesis and are active against cultures of Vero and 
HeLa cells. These Shiga-like toxins have been called 
verotoxin I (VTI) and verotoxin 2 (VT2). Isolates of 
human origin most commonly produce either VT2 or 
both VTI and VT2. Over 62 different phage types have 
been recognised. Other less common EHEC serotypes 
causing disease in man include 026:H 11, 0111 :H8 and 
0104:H21. 
The detection of E coli 0157:H7 in stools by using an 
appropriate selective and differential medium is a 
relatively straightforward and inexpensive procedure . 
Moreover, the labour involved in the review of plates is 
minimal. The toxin/s can also be detected directly from 
the stools by enzyme-linked immunosorbent assay 
techniq ues . Other laboratory diagnostic strategies are 
also available. 
Irrespective of the method used, early collection of 
faecal specimens for detecting E coli 0157 :H7 is 
imperative. A positive culture is to be expected in 100% 
specimens collected within two days of onset of 
symptoms: this proportion drops to 33 % if the sample is 
taken seven days or more from onset 22. 
Antibiotic therapy of E coli 0157 :H7 infection is not 
usually recommended since it is generally ineffective 
and may even result in a worsening of the condition due 
to further release of toxin from killed intracolonic 
bacteria23 . Subinhibitory concentrations of cotrim oxazole 
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have been shown to increase the production of Shiga-like 
toxin in vitro 24. The prophylactic use of antibiotics is 
contraindicated; indeed this has been identified as a risk 
factor for the development of the condition 10.12 Orally 
administered toxin-binding resins and antitoxin gIven 
intravenously 25 seem to hold more promise. 
The local situation 
. Plans to introduce laboratory diagnostic facilities for E 
coli 0157:H7 at St Luke's Hospital were made in 1993, 
and the service was eventually introduced in September 
1994. Thanks to the introduction of this new diagnostic 
service, SLH Bacteriology Laboratory joined the 
European VTEC Club in 1994. The Club promotes 
communication amongst various groups throughout 
Europe studying EHEC infection. 
It is currently the policy to screen routinely all stool 
specimens submitted for culture. All isolates of E coli 
0157:H7 are referred to the Public Health Laboratory in 
Valletta for phage typing and toxigenicity tests. 
So far, two patients have been diagnosed with E coli 
0157:H7 infection, while a third clinically suggestive 
case could not be confil111ed bacteriologically, possibly 
due to late submission of the stool specimen. The first 
two cases are the subject of an article in this issue 26. 
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